CPRX
Catalyst Pharmaceuticals Inc
31.50$
+0.0%
vs. previous close
Closing price · As of: Jul 21, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | – | – | – | 3,983.8% | 14.4% | 14.3% | 15.5% | 16.1% | 13.1% | 14.0% | 14.8% | |
| – | – | – | – | 100.0% | 85.6% | 85.7% | 84.5% | 83.9% | 86.9% | 86.0% | 85.2% | |
| – | – | – | – | 3,983.8% | 18.4% | 13.9% | 12.0% | 9.2% | 23.4% | 2.6% | 2.2% | |
| – | – | – | – | 3,175.2% | 36.0% | 17.4% | 16.7% | 13.4% | 11.8% | 34.1% | 12.1% | |
| – | – | – | – | 7,159.0% | 54.5% | 51.0% | 47.3% | 36.4% | 65.1% | 46.3% | 41.4% | |
| – | – | – | – | -7,059.0% | 31.1% | 34.7% | 37.2% | 47.5% | 21.8% | 39.7% | 43.8% | |
| – | – | – | – | 258.3% | 1.8% | 1.2% | 0.3% | 1.9% | – | – | – | |
| – | – | – | – | -6,800.7% | 32.7% | 35.2% | 37.4% | 48.9% | 23.7% | 44.0% | 48.1% | |
| – | – | – | – | 516.7% | 1.5% | -27.8% | 9.4% | 10.1% | 5.8% | 10.7% | 11.7% | |
| – | – | – | – | -6,800.7% | 31.2% | 63.0% | 28.0% | 38.8% | 17.9% | 33.3% | 36.4% | |
| – | – | – | – | -7,051.4% | 31.4% | 35.4% | 37.3% | 48.1% | 32.0% | 51.7% | 54.6% |
Data as of: July 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.